Delivery Order SPE2DR25D3012-SPE2DR26F4C5F
- Not listed
- The Defense Logistics Agency awarded a $60,897.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of December 5, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,575.13 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Prolia 60 mg/ml syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery is scheduled for completion by October 23, 2025, with performance taking place at...
- The Defense Logistics Agency awarded a delivery order valued at $12,697.07 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes with a firm fixed price. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and involves no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $26,999.75 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed price contract is non-competitive with no set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,571.60 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of November 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,729.55 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes, with an ultimate completion date of December 10, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded on a competitive basis. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,054.74 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of November 21, 2025. This competitive award, issued on November 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,886.29 by the Defense Logistics Agency (DLA) on October 23, 2025, with an ultimate completion date of October 24, 2025. The order is for Prolia 60 mg/ml syringes and represents a firm fixed price, competitively awarded contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,071.75 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, valued at $9,104.04 under firm fixed price terms. The award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C5FDelivery Order
The Defense Logistics Agency awarded a $30,542.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Prolia 60 mg/ml syringe. This non-set-aside contract represents a single delivery order placed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. As one of the federal government's major pharmaceutical distributors, AmerisourceBergen Drug Corp supplies critical medical commodities to military healthcare systems and the Defense Health Agency through its comprehensive global pharmaceutical support contract. This delivery order for Prolia, a bone health medication used primarily in osteoporosis treatment, exemplifies the company's role in fulfilling specialized pharmaceutical procurement needs across the Defense Medical Supply Chain. The award maintains AmerisourceBergen's established pattern of competitively awarded, firm fixed-price contracts for pharmaceutical products supporting federal military and veteran healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.5k | 11/30/25 |